Don’t invest unless you’re prepared to lose all your money. These are high-risk investments and you are unlikely to be protected if something goes wrong.
Take 2 mins to learn more

Latest News

Latest news and updates directly from our blog.
Supporting ClinSpec Diagnostics Ltd

Norcliffe Capital are proud to support ClinSpec Diagnostics Ltd and the future of cancer diagnostics. ClinSpec Dx, a Glasgow based spin out from the University of Strathclyde, have developed a cancer diagnostics system using a simple blood test analysis to accelerate the time it takes to diagnose cancer. Based on the world-leading research of Dr Matthew Baker,...

Completion of a £6 million fundraise for Biosceptre International.

Norcliffe Capital are pleased to announce the completion of a £6 million fundraise for Biosceptre International. Biosceptre International are developing groundbreaking CAR T cancer therapeutics with a unique target that is only found on cancer cells, not normal cells, that should mitigate the usual side effects associated with cancer treatments. Biosceptre is such an exciting...